Glutathione is one of the body's main antioxidants. It helps neutralize reactive molecules and supports enzymes involved in processing certain drugs and other compounds. Whether glutathione supplements "work" depends on the form, dose, how long it is taken, and what outcome is measured. When taken consistently for months, glutathione increases measured levels in the body, but its ability to treat disease or improve health has not been established.
- With consistent dosing over months, glutathione supplements can raise measured blood levels. One-time doses and short trials showed no change.
- Glutathione levels returned to baseline after stopping treatment, suggesting that its benefits, if any, depend on continued use.
- A few small, industry-sponsored studies show changes in early biomarkers for glutathione function, but have not proven any health benefit.
- Clinical evidence for glutathione is limited to preliminary, condition-specific studies showing improved lab measures, but no clinical outcome.
- Glutathione's form and dose impact how well it is absorbed and whether it elevates measured levels.
Does glutathione work?
It can, depending on what "work" means. When taken consistently for months, glutathione can raise the body's measured levels of glutathione and markers of glutathione function. Evidence has not established that glutathione supplements can treat disease or improve general health and wellness.
Early short and single-dose glutathione studies found no change in measured blood levels.1,2 More recent trials provide stronger evidence that sustained high doses can increase measured glutathione.3,4
These small trials also show that high doses of glutathione taken daily can affect lab measures for immune function, oxidative stress, and cellular damage caused by an excess of harmful free radicals and insufficient antioxidants to neutralize them. Evidence that it can improve overall health or treat disease is weaker and not well established.
What does it mean for glutathione to "work"?
There are several ways to measure whether glutathione supplementation "works", and studies typically evaluate only one or two. Some key measures include absorption, raising measured levels, improving a lab biomarker, improving a clinical outcome, and treating a disease.
A biomarker is a lab measurement that indicates something happening in the body, such as glutathione levels or an oxidative stress reading. A clinical outcome is a measurable change in a person's health or well-being, such as liver enzymes, blood sugar, symptoms, or quality of life.
A change in a biomarker is not the same as a clinical outcome or a disease treatment. Studies finding that glutathione increased blood levels and improved oxidative stress and immune function biomarkers are not evidence that it can treat a disease or improve general wellness.
The benefits, graded by evidence
The strongest evidence for glutathione comes from its core biology and its roles as the body's main antioxidant and a detoxifying agent. Most other marketed benefits are preliminary, weak, or marketing claims.
| Benefit or claim | What the evidence shows | Evidence strength |
|---|---|---|
| Antioxidant defense | The body produces its own glutathione, which neutralizes free radicals and helps recycle other antioxidants.5,6 These functions are glutathione's core biology and are not proof of a supplement's benefit. | Strong as biology; evidence of supplement benefit is limited |
| Detoxification and liver support | Glutathione acts as a cofactor for enzymes that clear the body of drugs and foreign compounds. It is most highly concentrated in the liver.7,8 This is the basic biochemical role, not a "toxin flush." | Strong as biology; not evidence of a supplement "cleanse" |
| Immune markers | Supplemental glutathione was associated with increased natural killer cells in small trials.3,4 This lab measure change is not proof of reduced infections. | Moderate — supported but preliminary |
| Skin and pigmentation | Glutathione may reduce melanin. Oral and topical routes show modest, typically short-lived effects in small studies. The injected route is weakly supported, potentially unsafe, and not FDA-approved.9 | Preliminary for oral/topical; weak with safety concerns for injected |
| Aging and longevity | Lower glutathione levels are associated with aging and certain chronic illnesses.10,11 These associations are not evidence that increasing it will affect aging or chronic illness. | Weak — association, not proven cause |
| Specific conditions (liver, diabetes, Parkinson's) | Glutathione has been evaluated in small or preliminary trials with mixed or single-condition results. | Preliminary — mixed and condition-specific |
| General "detox" and energy | Research does not provide evidence to support broad wellness claims. | Weak — marketing claims with little rigorous support |
Is oral glutathione absorbed, and does it raise levels?
Older single-dose studies found little change in measured glutathione, but longer daily use can raise levels. Dose and duration determine whether oral glutathione is absorbed and raises measured blood levels.
In a 1992 academic pilot study, seven healthy adults received a single dose of 3,000 mg of oral glutathione, with no observed increase in measured blood glutathione.1 A similarly null result was observed in a 2011 randomized, double-blind, placebo-controlled trial, in which 40 healthy adults received 1,000 mg/day of oral glutathione (500 mg twice daily) for four weeks.2
Later industry-sponsored trials found that longer, consistent dosing raised measured blood levels. A 2015 randomized, double-blind, placebo-controlled study dosed 54 healthy adults with 250 mg/day or 1,000 mg/day of glutathione over six months. In the high-dose group, measured levels increased approximately 30 to 35% in blood and 260% in cheek cells.3 This study used the same dose (1,000 mg/day) as the 4-week trial, underscoring the importance of dose duration.
Formulation may affect how well oral glutathione is absorbed. A small, single-arm pilot study in 12 healthy adults who received 500 mg/day or 1,000 mg/day of liposomal glutathione for a month reported that whole blood levels increased 40% within two weeks.4 Liposomal formulations use protective vesicles made of fat to deliver drugs inside the body.
A 2026 randomized crossover trial compared a single dose of 500 mg of standard oral glutathione, 300 mg of liposomal oral glutathione, and 300 mg of micellar oral glutathione in 14 healthy adults.12 The trial reported around a 2.5 times higher glutathione exposure from the micellar treatment compared to standard, despite the lower dose. The micellar treatment also achieved around 2 times higher exposure than the liposomal treatment. In the trial's second phase, the same 14 participants received 600 mg/day of micellar glutathione for 30 days, and the treatment was found to be safe and well tolerated in healthy adults.
These studies provide evidence that formulation may affect how much glutathione reaches the bloodstream, but not that elevated levels in the bloodstream have any health benefit. In the 6-month trial, glutathione dropped back to baseline within a month of ending treatment, suggesting that increased levels depend on continued use.3
Does raising glutathione actually improve health?
Some studies found that lab measures improved, but strong proof of noticeable benefits is limited and depends on the health condition. A change in a biomarker is not the same as a clinical outcome or health benefit.
The 6-month trial reported reduced signs of oxidative stress and more than double the activity of natural killer cells, immune cells that destroy virally infected cells and newly formed cancer cells.3 Similar increases in biomarkers of oxidative stress and immune function were observed in the liposomal glutathione pilot study.4
These results show only that glutathione may impact lab markers; they are not proof that it will treat or prevent illness or promote better overall health. Participants in clinical trials may have significant improvements in biomarkers, with no noticeable change in clinical outcome or symptoms. Likewise, participants may feel better or experience health changes with no alteration to biomarkers. Studies that show results in people with a specific condition do not automatically apply to healthy individuals.
What does the evidence show condition by condition?
The strongest evidence for glutathione is from single-condition studies, which identified early biological indicators of potential benefits rather than broad proof of improvements or a clinical outcome.
Liver (fatty liver disease): A small, single-arm, open-label pilot study included 29 patients with nonalcoholic fatty liver disease (now called metabolic dysfunction-associated steatotic liver disease).13 Participants saw a decrease in the liver enzymes alanine aminotransferase (ALT) and other liver biomarkers after four months of 300 mg/day of oral glutathione. The study had no control group, and treatment was preceded by three months of diet and exercise, making the effects of glutathione, if any, difficult to discern.
Type 2 diabetes: In an open-label, randomized trial, 125 adults with diabetes already taking standard diabetes medication received 500 mg/day of oral glutathione for six months and showed higher measured glutathione and decreased markers of oxidative stress and DNA damage.14 HbA1c was steady throughout the study and showed improvement only after patients over 55 were analyzed separately. The study lacked a placebo group.
Parkinson's disease: A small randomized, double-blind, placebo-controlled trial enrolled 45 individuals with Parkinson's disease who received a dose of saline nasal spray, 300 mg/day of nasal spray glutathione, or 600 mg/day of nasal spray glutathione.15 After three months, all groups improved and neither treatment group beat the placebo, suggesting that glutathione was not the cause of the improvement.
Immune markers: Increases in natural killer cell activity were reported in a 6-month trial and a 1-month liposomal pilot.3,4 Both trials were small and measured lab biomarkers, which are not evidence of fewer infections.
Aging and longevity: Research suggests that glutathione levels decline with age and are lower in people with many chronic illnesses.10,11 The association does not prove that supplementing glutathione will prevent or reverse aging or treat chronic conditions.
Skin tone: Results from small studies of glutathione marketed to lighten skin and improve skin tone, based on its role in melanin production, vary by formulation.9 Oral and topical forms have variable effectiveness and sustainability; injected glutathione marketed for skin lightening is not FDA-approved and may carry safety risks.
Human glutathione studies at a glance
| Study | Participants, form, dose, duration | Main result | Main limitation |
|---|---|---|---|
| Witschi, 1992 | 7 healthy adults; single 3,000 mg dose of oral glutathione | No meaningful increase in measured blood glutathione | Very small; tested only a single dose |
| Allen & Bradley, 2011 | 40 healthy adults; 1,000 mg/day for 4 weeks | No change in RBC glutathione or oxidative stress markers | Duration may have been too short |
| Richie, 2015 | 54 adults; 250 or 1,000 mg/day for 6 months | Higher-dose group: ~30–35% increase in blood, 260% in cheek cells. Levels returned to baseline after 1 month washout. | Manufacturer-funded; laboratory outcomes |
| Sinha, 2018 | 12 healthy adults; 500 or 1,000 mg/day liposomal for 1 month | Increased measured glutathione and changes in oxidative stress and immune biomarkers | Small, no placebo; industry-connected |
| Solnier, 2026 | 14 healthy adults; single doses of standard, liposomal, and micellar oral glutathione | Micellar formulation produced greater measured exposure than standard | Single-dose exposure study; industry-connected |
| Honda, 2017 | 29 completed; 300 mg/day for 4 months after 3 months of diet and exercise | ALT and other liver-related markers decreased | No control group; prior lifestyle intervention confounds |
| Kalamkar, 2022 | 125 adults with T2D; standard care + 500 mg/day for 6 months | Glutathione levels rose; oxidative DNA damage decreased; HbA1c overall stable | Unblinded, no placebo; HbA1c reduction only in a subgroup >55 |
| Mischley, 2017 | 45 adults with Parkinson's; placebo, 300 or 600 mg/day intranasal for 3 months | All groups improved; glutathione did not beat placebo | Small, condition-specific |
Does glutathione detox the body?
The body's own glutathione supports normal liver processes, helps clear harmful substances, and is the basis of acetaminophen (Tylenol) overdose treatment.16,17,18 Contrary to some wellness marketing claims, glutathione supplements do not "flush toxins" or "cleanse" a healthy body.
The kidney and liver are the body's primary detoxifiers, and glutathione supports the function of both. Heavily concentrated in the liver, it neutralizes harmful compounds, allowing them to be safely eliminated.16 In the kidney, glutathione helps protect the cells that filter waste against oxidative stress and damage.17 N-acetylcysteine (NAC), an amino acid derivative, treats acetaminophen overdose by replenishing depleted glutathione levels.18
For a deeper look at the detox question specifically, see our companion piece: Glutathione and detox: what it does, what it doesn't, and what the science says.
How long does it take, and do the benefits last?
Small trials that found an effect involved 3 to 6 months of daily glutathione use, and the reported benefits ended after stopping treatment. Single-dose and short-term studies generally showed little to no effect. In a 6-month trial in which 54 adults received 250 mg/day or 1,000 mg/day of oral glutathione, measured blood levels returned to baseline within a month of stopping treatment.3
What the evidence does not show
Research does not show that glutathione supplements can cure or prevent disease or improve overall health. Clinical studies are limited and preliminary. Studies reporting changes in lab measures and biomarkers are not evidence that the supplements will improve a person's well-being or general health. There is not well-established evidence to support broad marketing claims that glutathione supplements can "detox" or "boost energy."
Oral glutathione was well tolerated in the trials described above, at doses from 250 mg/day to 1,000 mg/day for up to six months, with no serious adverse effects reported. In the 30-day extension phase of the 2026 crossover study, participants taking 600 mg/day showed no significant changes in liver enzymes or in creatinine, a marker of kidney function.12 These were small studies not designed to detect uncommon harms, and none ran longer than six months. Injectable and intravenous forms carry a different and more serious risk profile.9
Study results in people with specific health conditions or using a specific formulation are not proof that results will apply to everyone or that oral, liposomal, micellar, injectable, and IV forms are interchangeable in effect.
Where glutathione fits in a broader longevity picture
Glutathione is one node in a broader landscape of longevity-marketed supplements. For context on how it compares with other options — and which are actually supported by human evidence — see our longevity supplements overview and our pieces on NAD+ supplements and NMN vs. NR.
Conclusion
Glutathione supplements can raise measured blood levels when taken regularly over a period of months, with a few small studies also showing early biomarkers of glutathione function. Clinical evidence for the broad health benefits of glutathione is not well established, and condition-specific research is limited to small, preliminary trials. Reported benefits appear to depend on consistent and continued use. Discuss your symptoms, medical history, and options with a licensed clinician.
Frequently asked questions
How long does glutathione take to work?
When taken regularly for 3 to 6 months, it can increase measured glutathione. Evidence that taking glutathione for any length of time can cure or prevent disease or provide broad health benefits is not well established.
Is liposomal glutathione better than regular glutathione?
There's not enough evidence to say. An industry-sponsored trial in 12 healthy adults found that daily oral liposomal glutathione raised whole blood levels 40% after two weeks.4 The trial's small size and lack of a placebo group limit direct comparison to previous trials of standard oral glutathione.3
Does glutathione help the liver?
Your body's own glutathione does. The liver produces glutathione, which neutralizes toxic compounds, such as harmful drug byproducts and heavy metals, so that they can be cleared from the body.16 This is a core biological function of the antioxidant and is not evidence that glutathione supplements improve liver function or "cleanse" toxins.
Is glutathione better than NAC?
While clinical evidence for glutathione is preliminary, NAC has been a standard treatment for acetaminophen overdose since the 1970s, due to its ability to replenish glutathione levels.18 Research that NAC or glutathione supplements have general health benefits is limited and not well established.
Do you keep the benefits if you stop taking it?
No, according to the limited research available. The strongest trial showing that consistent glutathione use over six months raised measured levels, found that they returned to baseline within a month of ending treatment.3
Is glutathione good for your skin?
Clinical evidence is limited, and the reported effects on skin and safety vary widely depending on form. Oral and topical glutathione is associated with modest changes in skin brightness and pigmentation.9 Intravenous glutathione for skin tone is associated with severe health risks, prompting a health advisory from the Philippines Food and Drug Administration in 2019.
Does glutathione help with aging?
Your glutathione levels decline as you age.10 This natural process is not evidence that a glutathione supplement will slow or reverse signs of aging.
Does glutathione actually detox the body?
One of the biological functions of your body's glutathione is to help clear toxins from the body.7,8 Evidence that supplemental glutathione can do the same is not established.
References
- Witschi A, et al. 1992. Available at: doi.org/10.1007/bf02284971
- Allen J, Bradley RD. 2011. Available at: doi.org/10.1089/acm.2010.0716
- Richie JP, et al. 2015. Available at: doi.org/10.1007/s00394-014-0706-z
- Sinha R, et al. 2018. Available at: doi.org/10.1038/ejcn.2017.132
- Ristoff E, Larsson A. 2007. Available at: doi.org/10.1186/1750-1172-2-16
- Emerging Regulatory Paradigms in Glutathione Metabolism. Adv Cancer Res, 2014. Available at: doi.org/10.1016/b978-0-12-420117-0.00002-5
- Wu G, et al. 2004. Available at: doi.org/10.1093/jn/134.3.489
- Forman HJ, et al. 2009. Available at: doi.org/10.1016/j.mam.2008.08.006
- Alzahrani TF, et al. 2025. Available at: doi.org/10.7759/cureus.78045
- Bradauskienė V, et al. 2026. Available at: doi.org/10.3390/nu18101640
- Hristov BD. 2022. Available at: doi.org/10.7759/cureus.29696
- Solnier J, et al. 2026. Available at: doi.org/10.3390/antiox15030354
- Honda Y, et al. 2017. Available at: doi.org/10.1186/s12876-017-0652-3
- Kalamkar S, et al. 2022. Available at: doi.org/10.3390/antiox11051026
- Mischley LK, et al. 2017. Available at: doi.org/10.3233/JPD-161040
- Vairetti M, et al. 2021. Available at: mdpi.com/2076-3921/10/3/364
- Lash LH. 2024. Available at: doi.org/10.1016/j.bcp.2024.116181
- Kalsi S, et al. 2011. Available at: doi.org/10.2147/oaem.s24963